Shire to sell oncology business to Servier for $2.4 billion

LONDON (Reuters) - Shire , the London-listed pharmaceutical company which specialises in rare diseases, said on Monday it was selling its oncology business to French drug maker Servier for $2.4 billion (£1.7 billion).


From our friends over at the : Reuters: Top News


You can see the Full Story: Click Here